Reporting guideline provided for? (i.e. exactly what the authors state in the paper)
Reporting of risk minimisation programme evaluations.
Full bibliographic reference
Smith MY, Morrato EH, Mora N, Nguyen V, Pinnock H, Winterstein AG. The Reporting Recommendations Intended for Pharmaceutical Risk Minimization Evaluation Studies: Standards for Reporting of Implementation Studies Extension (RIMES-SE). Drug Saf. 2024.
Language
English
PubMed ID
Relevant URLs (full-text if available)
The checklist is available in Supplemental File 3 (PDF).
Explanation and elaboration papers
The E&E document is available in Supplemental File 4 (PDF).
Relevant more generic / specialised reporting guidelines (i.e. main generic guideline or extension to a generic guideline)
Generic
StaRI: Pinnock H, Barwick M, Carpenter CR, Eldridge S, Grandes G, Griffiths CJ, Rycroft-Malone J, Meissner P, Murray E, Patel A, Sheikh A, Taylor SJC, for the StaRI group. Standards for Reporting Implementation Studies (StaRI) statement. BMJ. 2017;356:i6795. PMID: 28264797
Reporting guideline acronym
RIMES-SE
Study design
Mixed methods studies, Observational studies
Clinical area
Pharmaceutical medicine, Public health
Applies to the whole report or to individual sections of the report?
Whole report
Record last updated on
June 12, 2024
Training
The UK EQUATOR Centre runs training on how to write using reporting guidelines.